Sonnet BioTherapeutics Holdings, Inc. (SONN) Social Stream
SONNET BIOTHERAPEUTICS HOLDINGS INC (SONN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SONN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-15 | 1 | $8 | $5 | $6.5 | $1.615 | 302.48% |
| 2021-12-16 | 2 | $8 | $2 | $5 | $1.615 | 209.6% |
| 2022-02-10 | 3 | $5 | $2 | $3.166 | $1.615 | 96.04% |
| 2022-05-11 | 2 | $5 | $2.5 | $3.75 | $1.615 | 132.2% |
| 2022-08-17 | 1 | $28.011 | $28.011 | $28.011 | $1.615 | 1634.43% |
| 2022-09-22 | 1 | $22 | $22 | $22 | $1.615 | 1262.23% |
| 2022-12-19 | 2 | $22 | $6.7 | $14.35 | $1.615 | 788.54% |
| 2023-04-19 | 2 | $17 | $7 | $12 | $1.615 | 643.03% |
| 2023-05-11 | 2 | $14 | $7 | $10.5 | $1.615 | 550.15% |
| 2023-05-25 | 2 | $14 | $6.7 | $10.35 | $1.615 | 540.87% |
| 2023-08-16 | 2 | $12 | $12 | $12 | $1.615 | 643.03% |
| 2023-08-23 | 2 | $263.736 | $147.274 | $205.505 | $1.615 | 12624.77% |
| 2023-09-01 | 2 | $147.274 | $75 | $111.137 | $1.615 | 6781.55% |
| 2023-11-27 | 3 | $147.274 | $7 | $76.424 | $1.615 | 4632.14% |
The Trend in the Analyst Price Target
SONN's average price target has moved up $68.42 over the prior 32 months.
Over the past 32 weeks, SONN's average upside potential has been 8,594.87%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-25 | 2 | 14.000 | 6.700 | 10.350 | 0.40 | 2487.5% |
| 2023-08-16 | 2 | 12.000 | 12.000 | 12.000 | 0.38 | 3057.89% |
| 2023-08-23 | 2 | 12.000 | 6.701 | 9.350 | 0.29 | 3124.14% |
| 2023-09-01 | 2 | 147.274 | 75.000 | 111.137 | 4.67 | 2279.81% |
| 2023-11-27 | 3 | 147.274 | 7.000 | 76.424 | 1.49 | 5029.13% |
SONN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 48 weeks, SONN's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, SONNET BIOTHERAPEUTICS HOLDINGS INC's number of analysts covering the stock is higher than 69.14% of them.
- In terms of how SONNET BIOTHERAPEUTICS HOLDINGS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1920.49% of that group.
- In terms of how SONNET BIOTHERAPEUTICS HOLDINGS INC fares relative to all US stocks, note that its average analyst price target is higher than 505.93% of that group.
- SONN has a lower variance in analysts' estimates than -1188.39% of stocks in the micro market cap category.
In the Pharmaceutical Products industry, SNGX, ADTX, and IPA are the three stocks most similar to SONNET BIOTHERAPEUTICS HOLDINGS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding SONN using the data that counts. Try POWR Ratings for free.